Disorders Caused by Genetic Mosaicism
- 21 February 2020
- journal article
- review article
- Published by Deutscher Arzte-Verlag GmbH in Deutsches Ärzteblatt international
- Vol. 117 (8), 119-+
- https://doi.org/10.3238/arztebl.2020.0119
Abstract
Background: Genetic mosaics arise through new mutations occurring after fertilization (i.e., postzygotic mutations). Mosaics have been described in recent years as the cause of many different disorders: many of these are neurocutaneous diseases and syndromal developmental disorders, each with a characteristic phenotype. In some of these disorders, there is a genetic predisposition to the development of tumors. This article is intended as an overview of selected mosaic diseases. Methods: This review is based on publications retrieved by a selective search in PubMed, with particular attention to recent articles in high-ranking journals dealing with asymmetric growth disturbances, focal brain malformations, mosaic diseases due to dysregulation of the RAS/RAF signaling pathway (mosaic RASopathies). and vascular malformations. Results: The identification of postzygotic mutations has led to the reclassification of traditional disease entities and to a better understanding of their pathogenesis. Diagnosis is aided by modern next-generation sequencing (NGS) techniques that allow the detection even of low-grade mosaics. Many mosaic mutations are not detectable in blood, but only in the affected tissue, e.g., the skin. Genetic mosaic diseases often manifest themselves in the skin and brain, and by facial dysmorphism, asymmetrical growth disturbances. and vascular malformations. Conclusion: The possibility of a mosaic disease should be kept in mind in the diagnostic evaluation of patients with asymmetrical growth disturbances, focal neuronal migration disturbances, vascular malformations, and linear skin abnormalities. The demonstration of a postzygotic mutation often affords relief to the parents of an affected child, since this means that there is no increased risk for recurrence of the same disorder in future children. Correct classification is important, as molecular treatment approaches are already available for certain mosaic diseases, e.g.. PIK3CA-related overgrowth spectrum (PROS) disorder.This publication has 42 references indexed in Scilit:
- Sturge–Weber Syndrome and Port-Wine Stains Caused by Somatic Mutation inGNAQThe New England Journal of Medicine, 2013
- Congenital melanocytic nevi: Where are we now?Journal of the American Academy of Dermatology, 2012
- De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromesNature Genetics, 2012
- Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndromeNature Genetics, 2012
- A Mosaic Activating Mutation inAKT1Associated with the Proteus SyndromeThe New England Journal of Medicine, 2011
- Encephalocraniocutaneous lipomatosisJournal of Medical Genetics, 2009
- Parallel sequencing used in detection of mosaic mutations: Comparison with four diagnostic DNA screening techniquesHuman Mutation, 2009
- Expanding the phenotype of oculoectodermal syndrome: Possible relationship to encephalocraniocutaneous lipomatosisAmerican Journal of Medical Genetics Part A, 2007
- Capillary Malformation–Arteriovenous Malformation, a New Clinical and Genetic Disorder Caused by RASA1 MutationsAmerican Journal of Human Genetics, 2003
- 21-TRISOMY/NORMAL MOSAICISM: in an Intelligent Child with some Mongoloid CharactersThe Lancet, 1961